Scrip: the finger on pharma’s pulse for more than 35 years.
Scrip is subscribed to by 98 of the world’s top 100 pharma companies, leading biotech innovators and other key market players: Scrip reaches 8,500 registered subscribers worldwide that need current and independent biopharma business information that they can trust. Scrip's website attracts over 30,000 unique users every month.
Scrip is read by 100,000+ biopharma decision-makers worldwide, 80% of whom are actively involved in the buying process
An annual subscription to SCRIPIntelligence includes:
- Full access to Scripintelligence.com – providing online access to all Scrip content and updated throughout the day
- Daily email alerts
- Up to 25 customised email alerts – alerting you the moment we publish content relevant to your search term
- Weekly issues of the newsletter (in print or PDF)
- Searchable online archive of all Scrip news, data and analysis published since 1995
- PDF library including;
- Scrip World Pharmaceutical News
- Pipeline Watch
- Market Insights
- Executive Briefings
- Scrip Reports
- Scrip S upplements
- Analysis in every issue – Market Insights into key trends and developments
- In-depth Executive Briefings every month on regional markets and business development activities
- Monthly Pipeline Watch (data on worldwide late-stage clinical developments)
- Scrip Clinical Research - full access to scripclinicalresearch.com and 6 issues a year of unique business intelligence about the outsourced clinical trial sector
- The Scrip 100 supplement
- The Scrip Pharmaceutical Companies League tables
- XML data feed for key account clients
Pricing and order details:
Entre em contato e Solicite seu orçamento:
------------------------------------------------
Authorized Subscription Agency - Booksellers - Information Consultant
---------------------------------------------------------------------------------
